• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Kalbe Farma Tbk PT

+ Add to Watchlist

KLBF:IJ

1,730 IDR 20 1.14%

As of 05:11:55 ET on 07/25/2014.

Snapshot for Kalbe Farma Tbk PT (KLBF)

Open: 1,730 Day's Range: 1,710 - 1,750 Volume: 71,385,200
Previous Close: 1,750 52wk Range: 1,110 - 1,800 1-Yr Rtn: +22.26%

Stock Chart for KLBF

No chart data available.
  • KLBF:IJ 1,730
  • 1D
  • 1M
  • 1Y
1,750
Interactive KLBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KLBF

Current P/E Ratio (ttm) 40.2859
Estimated P/E(12/2014) 36.1554
Relative P/E vs. JCI 2.0338
Earnings Per Share (IDR) (ttm) 42.9430
Est. EPS (IDR) (12/2014) 47.8490
Est. PEG Ratio 2.2873
Market Cap (M IDR) 81,093,961.25
Shares Outstanding (M) 46,875.12
30 Day Average Volume 48,802,060
Price/Book (mrq) 9.7658
Price/Sale (ttm) 4.7813
Dividend Indicated Gross Yield 0.98%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 46.72%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KLBF

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for KLBF

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for KLBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil